Cytosorbents Corp

+0.07 (+0.84%)
Earnings Announcements

Cytosorbents Reports Q1 2021 Financial And Operational Results

Published: 05/04/2021 20:57 GMT
Cytosorbents Corp (CTSO) - Cytosorbents Reports First Quarter 2021 Financial and Operational Results.
Q1 Revenue $10.6 Million.
Expect Our Q2 2021 Product Sales Will Exceed Product Sales Reported in Q2 of 2020.
Qtrly Loss per Share $0.10.
Q1 Earnings per Share View $-0.03, Revenue View $11.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $12.27 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $13.07 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.